Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 7 (2010), Issue 10 (October)

1. Microfibrillar collagen hemostat-induced necrotizing granulomatous inflammation developing after craniotomy: a pediatric case series.
   J Neurosurg Pediatr, 6(4): 385-92. [Abstract] [Full-text]
2. Rapamycin as an alternative to surgical treatment of subependymal giant cell astrocytomas in a patient with tuberous sclerosis complex.
   J Neurosurg Pediatr, 6(4): 381-4. [Abstract] [Full-text]
3. Posterior reversible encephalopathy syndrome during posterior fossa tumor resection in a child.
   J Neurosurg Pediatr, 6(4): 377-80. [Abstract] [Full-text]
4. Metachronous multifocal desmoid-type fibromatoses along the neuraxis with adenomatous polyposis syndrome.
   J Neurosurg Pediatr, 6(4): 372-6. [Abstract] [Full-text]
5. Postoperative imaging surveillance in pediatric pilocytic astrocytomas.
   J Neurosurg Pediatr, 6(4): 346-52. [Abstract] [Full-text]
6. Small ventricular access prior to rigid neuroendoscopy.
   J Neurosurg Pediatr, 6(4): 325-8. [Abstract] [Full-text]
7. Up-regulation of EphA2 and down-regulation of EphrinA1 are associated with the aggressive phenotype and poor prognosis of malignant glioma.
   Tumour Biol, 31(5): 477-88. [Abstract] [Full-text]
8. Stereotactic radiosurgery for deep-seated cavernous malformations: a move toward more active, early intervention. Clinical article.
   J Neurosurg, 113(4): 691-9. [Abstract] [Full-text]
9. The presigmoid approach to anterolateral pontine cavernomas. Clinical article.
   J Neurosurg, 113(4): 701-8. [Abstract] [Full-text]
10. Nationwide study of decompressive surgery for malignant supratentorial infarction in the Czech Republic: utilization and outcome predictors. Clinical article.
    J Neurosurg, 113(4): 897-900. [Abstract] [Full-text]
11. Radiation-induced glioblastoma multiforme in children treated for medulloblastoma with characteristics of both medulloblastoma and glioblastoma multiforme.
    J Pediatr Hematol Oncol, 32(7): e272-8. [Abstract] [Full-text]
12. Parents of children surviving a brain tumor: burnout and the perceived disease-related influence on everyday life.
    J Pediatr Hematol Oncol, 32(7): e285-9. [Abstract] [Full-text]
13. T-cell immunotherapy for malignant glioma: toward a combined approach.
    Curr Opin Oncol, 22(6): 604-10. [Abstract] [Full-text]
14. Epilepsy and brain tumors.
    Curr Opin Oncol, 22(6): 611-20. [Abstract] [Full-text]
15. Supportive care in neurooncology.
    Curr Opin Oncol, 22(6): 621-6. [Abstract] [Full-text]
16. Imaging and response criteria in gliomas.
    Curr Opin Oncol, 22(6): 598-603. [Abstract] [Full-text]
17. Inherited variation in immune genes and pathways and glioblastoma risk.
    Carcinogenesis, 31(10): 1770-7. [Abstract] [Full-text]
18. NG2-expressing glial precursor cells are a new potential oligodendroglioma cell initiating population in N-ethyl-N-nitrosourea-induced gliomagenesis.
    Carcinogenesis, 31(10): 1718-25. [Abstract] [Full-text]
19. Gamma-radiation sensitivity and polymorphisms in RAD51L1 modulate glioma risk.
    Carcinogenesis, 31(10): 1762-9. [Abstract] [Full-text]
20. ¹H nuclear magnetic resonance spectroscopy characterisation of metabolic phenotypes in the medulloblastoma of the SMO transgenic mice.
    Br J Cancer, 103(8): 1297-304. [Abstract] [Full-text]
21. Handling of solid brain tumor tissue for protein analysis.
    Methods Mol Biol, 675: 327-32. [Abstract] [Full-text]
22. Targeting SRC in glioblastoma tumors and brain metastases: rationale and preclinical studies.
    Cancer Lett, 298(2): 139-49. [Abstract] [Full-text]
23. Intracranial tumours after external fractionated radiotherapy for pituitary adenomas in northern Sweden.
    Acta Oncol, 49(8): 1276-82. [Abstract] [Full-text]
24. Targeting SRC in glioblastoma tumors and brain metastases: rationale and preclinical studies.
    Cancer Lett, 298(2): 139-49. [Abstract] [Full-text]
25. Targeting SRC in glioblastoma tumors and brain metastases: rationale and preclinical studies.
    Cancer Lett, 298(2): 139-49. [Abstract] [Full-text]
26. Monitoring blood-brain barrier status in a rat model of glioma receiving therapy: dual injection of low-molecular-weight and macromolecular MR contrast media.
    Radiology, 257(2): 342-52. [Abstract] [Full-text]
27. Coffee and tea intake and risk of brain tumors in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study.
    Am J Clin Nutr, 92(5): 1145-50. [Abstract] [Full-text]
28. Coffee and tea intake and risk of brain tumors in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study.
    Am J Clin Nutr, 92(5): 1145-50. [Abstract] [Full-text]
29. Masses of the pineal region: clinical presentation and radiographic features.
    Postgrad Med J, 86(1020): 597-607. [Abstract] [Full-text]
30. Validity of the graded prognostic assessment-derived index to predict brain-metastatic patients' survival after Gamma Knife radiosurgery.
    Int J Radiat Oncol Biol Phys, 78(4): 1156-62. [Abstract] [Full-text]
31. Use of 3.0-T MRI for stereotactic radiosurgery planning for treatment of brain metastases: a single-institution retrospective review.
    Int J Radiat Oncol Biol Phys, 78(4): 1142-6. [Abstract] [Full-text]
32. Effect of hyperoxygenation on tissue pO2 and its effect on radiotherapeutic efficacy of orthotopic F98 gliomas.
    Int J Radiat Oncol Biol Phys, 78(4): 1193-200. [Abstract] [Full-text]
33. Patterns and timing of recurrence after temozolomide-based chemoradiation for glioblastoma.
    Int J Radiat Oncol Biol Phys, 78(4): 1147-55. [Abstract] [Full-text]
34. Validity of the graded prognostic assessment-derived index to predict brain-metastatic patients' survival after Gamma Knife radiosurgery.
    Int J Radiat Oncol Biol Phys, 78(4): 1156-62. [Abstract] [Full-text]
35. Use of 3.0-T MRI for stereotactic radiosurgery planning for treatment of brain metastases: a single-institution retrospective review.
    Int J Radiat Oncol Biol Phys, 78(4): 1142-6. [Abstract] [Full-text]
36. Effect of hyperoxygenation on tissue pO2 and its effect on radiotherapeutic efficacy of orthotopic F98 gliomas.
    Int J Radiat Oncol Biol Phys, 78(4): 1193-200. [Abstract] [Full-text]
37. Factors associated with the development of brain metastases: analysis of 975 patients with early stage nonsmall cell lung cancer.
    Cancer, 116(21): 5038-46. [Abstract] [Full-text]
38. Patterns and timing of recurrence after temozolomide-based chemoradiation for glioblastoma.
    Int J Radiat Oncol Biol Phys, 78(4): 1147-55. [Abstract] [Full-text]
39. IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas.
    Neurology, 75(17): 1560-6. [Abstract] [Full-text]
40. MAPK pathway activation through BRAF gene fusion in pilocytic astrocytomas; a novel oncogenic fusion gene with diagnostic, prognostic, and therapeutic potential.
    J Pathol, 222(4): 324-8. [Abstract] [Full-text]
41. Anaphylactic reaction owing to ondansetron administration in a child with neuroblastoma and safe use of granisetron: a case report.
    J Pediatr Hematol Oncol, 32(8): e341-2. [Abstract] [Full-text]
42. Successful treatment of trilateral retinoblastoma with conventional and high-dose chemotherapy plus radiotherapy: a case report.
    J Pediatr Hematol Oncol, 32(8): e343-5. [Abstract] [Full-text]
43. Anaphylactic reaction owing to ondansetron administration in a child with neuroblastoma and safe use of granisetron: a case report.
    J Pediatr Hematol Oncol, 32(8): e341-2. [Abstract] [Full-text]
44. Successful treatment of trilateral retinoblastoma with conventional and high-dose chemotherapy plus radiotherapy: a case report.
    J Pediatr Hematol Oncol, 32(8): e343-5. [Abstract] [Full-text]
45. MRI changes associated with vigabatrin treatment mimicking tumor progression.
    Pediatr Blood Cancer, 55(6): 1221-3. [Abstract] [Full-text]
46. MRI changes associated with vigabatrin treatment mimicking tumor progression.
    Pediatr Blood Cancer, 55(6): 1221-3. [Abstract] [Full-text]
47. EGFRvIV: a previously uncharacterized oncogenic mutant reveals a kinase autoinhibitory mechanism.
    Oncogene, 29(43): 5850-60. [Abstract] [Full-text]
48. Child-related determinants of health-related quality of life in children with brain tumours 1 year after diagnosis.
    Pediatr Blood Cancer, 55(7): 1377-85. [Abstract] [Full-text]
49. Correlation between pre- or postoperative MRI findings and cerebellar sequelae in patients with medulloblastomas.
    Pediatr Blood Cancer, 55(7): 1310-6. [Abstract] [Full-text]
50. EGFRvIV: a previously uncharacterized oncogenic mutant reveals a kinase autoinhibitory mechanism.
    Oncogene, 29(43): 5850-60. [Abstract] [Full-text]
51. Child-related determinants of health-related quality of life in children with brain tumours 1 year after diagnosis.
    Pediatr Blood Cancer, 55(7): 1377-85. [Abstract] [Full-text]
52. Correlation between pre- or postoperative MRI findings and cerebellar sequelae in patients with medulloblastomas.
    Pediatr Blood Cancer, 55(7): 1310-6. [Abstract] [Full-text]
53. Child-related determinants of health-related quality of life in children with brain tumours 1 year after diagnosis.
    Pediatr Blood Cancer, 55(7): 1377-85. [Abstract] [Full-text]
54. Correlation between pre- or postoperative MRI findings and cerebellar sequelae in patients with medulloblastomas.
    Pediatr Blood Cancer, 55(7): 1310-6. [Abstract] [Full-text]
55. Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.
    J Clin Oncol, 28(31): 4722-9. [Abstract] [Full-text]
56. Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma.
    J Clin Oncol, 28(31): 4762-8. [Abstract] [Full-text]
57. Natural history of incidental World Health Organization grade II gliomas.
    Ann Neurol, 68(5): 727-33. [Abstract] [Full-text]
58. Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.
    J Clin Oncol, 28(31): 4722-9. [Abstract] [Full-text]
59. Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma.
    J Clin Oncol, 28(31): 4762-8. [Abstract] [Full-text]

© 2004-2012 Brain Cancer Research Today. All Rights Reserved.